Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Delivery of thermogenic genes to metabolic tissues: Effects on body weight and glucose tolerance. | Transl Res | 2025 | 40976537 | PubTator, text mining | PubMed |
| Advancements in Beta-Adrenergic Therapy and Novel Personalised Approach for Portal Hypertension: A Narrative Review. | Life (Basel) | 2025 | 40868821 | PubTator, text mining | PubMed |
| The Impact of Insulin Resistance on Lung Volume Through Right Ventricular Dysfunction in Diabetic Patients-Literature Review. | J Pers Med | 2025 | 40863398 | PubTator, text mining | PubMed |
| Repurposing Drug Metabolites into Dual β-Adrenergic Receptor-Carbonic Anhydrase Modulators as Potential Tools for Ocular Disorders. | J Med Chem | 2025 | 40857102 | PubTator, text mining | PubMed |
| Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes. | World J Urol | 2025 | 40856729 | PubTator, text mining | PubMed |
| Adipose tissue-targeted drug delivery for treating obesity: current opportunities and challenges. | Drug Deliv | 2025 | 40844426 | PubTator, text mining | PubMed |
| Exploring the role of β2- and β3-adrenergic receptors in cystic fibrosis. | Pulm Pharmacol Ther | 2025 | 40835024 | PubTator, text mining | PubMed |
| The dual GLP-1 and GIP receptor agonist tirzapetide provides an unintended interaction with the β-adrenoceptors and plays a role in glucose metabolism in hyperglycemic or senescent cardiac cells. | Cardiovasc Diabetol | 2025 | 40826463 | PubTator, text mining | PubMed |
| An explorative study on the interaction of cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1/ANRIL) gene polymorphism with obesity on periodontitis among Norwegian adults. | Acta Odontol Scand | 2025 | 40810409 | PubTator, text mining | PubMed |
| The multifaceted regulation of white adipose tissue browning and their therapeutic potential. | J Physiol Biochem | 2025 | 40785003 | PubTator, text mining | PubMed |
| A pre-menopausal single-cell atlas for ovarian drug discovery. | bioRxiv | 2025 | 40666883 | PubTator, text mining | PubMed |
| Retraction: Relationship between the Autoantibody and Expression of β3-Adrenoceptor in Lung and Heart. | PLoS One | 2025 | 40531852 | PubTator, text mining | PubMed |
| Distribution of Variants and Identification of Novel Variants in Patients with Obesity Using Next-Generation Sequencing in Genes Associated with Obesity: A Single-Center Experience in Turkey. | Mol Syndromol | 2025 | 40475165 | PubTator, text mining | PubMed |
| Investigating ADRB1 and ADRB3 polymorphisms as risk factors for type 2 diabetes: A retrospective study. | Gene | 2025 | 40441323 | PubTator, text mining | PubMed |
| Closing Editorial for the Special Issue: "Male Sexual and Reproductive Health: Clinical Aspects, Metabolic Profile, Environmental Factors and Lifestyle-Current Advances and Future Directions". | J Clin Med | 2025 | 40429338 | PubTator, text mining | PubMed |
| Fexaramine as the intestine-specific farnesoid X receptor agonist: A promising agent to treat obesity and metabolic disorders. | Drug Discov Today | 2025 | 40409402 | PubTator, text mining | PubMed |
| Hypoxia-Dependent Upregulation of VEGF Relies on β3-Adrenoceptor Signaling in Human Retinal Endothelial and Müller Cells. | Int J Mol Sci | 2025 | 40362282 | PubTator, text mining | PubMed |
| Impact of β3-adrenergic receptor agonist on kidney cancer risk in patients with overactive bladder. | BJU Int | 2025 | 40344609 | PubTator, text mining | PubMed |
| Serotonin Transporter Gene Polymorphisms Predict Adherence to Weight Loss Programs Independently of Obesity-Related Genes. | Nutrients | 2025 | 40292541 | PubTator, text mining | PubMed |
| Fatty Acylcarnitine Metabolism in Brown/Beige and White Fats by 13C HRMAS NMR Spectroscopy With Metabolic Interventions. | NMR Biomed | 2025 | 40230060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=5